Sara J Gourley is a litigation partner in the Chicago office and a member of the firm’s executive committee. Sara has substantial experience in pharmaceutical, medical device and blood products liability litigation. Her practice is concentrated in the areas of pharmaceutical and medical device defense, especially multi-jurisdictional coordination and defence of class actions. Sara is currently lead counsel for Takeda Pharmaceuticals in the ongoing MDL and related state court litigation regarding ACTOS including serving as trial counsel in the first related case to go to trial in state court. She has served in leading defence roles for clients in many of the pharmaceutical industry’s most significant litigation. She is also national counsel for a producer of blood products in AIDS and Hepatitis C litigation.
Sara speaks frequently on topics relating to the defense of product liability claims. Recent presentations include: “Approaches to Causation in Mass Torts”, “Transnational Product Liability Problems” and “The Role of Litigation in Regulating Drug Safety”. Sara also presented a paper to the Shanghai FDA on “Adverse Drug Reactions: A Discussion of United States and International Compensation Schemes”; published a 2012 update on US product liability law; and wrote a chapter on “Emerging Issues for Products Manufactured Overseas”, published in autumn 2009.
Sara is a member of the American Bar Association; the Illinois Bar Association; the International Association of Defense Counsel (IADC); and the Defense Research Institute (DRI), as well as DRI’s drug and medical device steering committee.
Sara received her JD (Law Review) from the University of Illinois College of Law in 1980 and her AB (cum laude, with honours in English) from Ripon College in 1977. Admissions include Illinois, and various US Court of Appeals and US District Courts.
WWL says: “A superstar of the bar” and “a superbly gifted litigator”
This biography is an extract from Who's Who Legal: Life Sciences which can be purchased from our Shop.